Endocrine oncology

Association Between Gross Features and Coexistence of BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features

ThyroidPublished Retrospective cohort study

Authors' conclusion

The BRAFV600E and TERT-p double mutation in PTC was significantly associated with relatively old age, larger tumor size, lobulated configuration in tumor margin, papillary excrescences on the cut surface, solid-cut surface, ETE, and high Ki-67 LI.

Study context

Population
Patients with papillary thyroid carcinoma (PTC) surgically resected January 2018–October 2023 at a single institution
Participants
375 patients
Exposure
PTC with vs without BRAFV600E and telomere reverse transcriptase promoter (TERT-p) double mutation
  • Double mutationn = 78
Outcome
Association of clinicopathologic features, including macroscopic features, with coexistent BRAFV600E and TERT-p mutations
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Factors associated with the double mutation (multivariable analysis)
Older age (≥55 years), OR
12.083 (4.498-32.456) (95% CI)
Tumor size >2.0 cm, OR
2.722 (1.104-6.712) (CI)
Lobulated tumor margins, OR
16.114 (3.155-82.296) (CI)
Papillary excrescences on cut surface, OR
17.573 (3.462-89.201) (CI)
Solid-cut surface, OR
4.012 (1.084-14.849) (CI)
Minimal extrathyroidal extension (ETE), OR
4.156 (1.209-14.282) (CI)
Gross ETE, OR
6.517 (1.734-24.490) (CI)
Ki-67 labeling index (LI) ≥5%, OR
12.145 (4.354-33.877) (CI)

Observational data: associations, not effects.

Further findings

Prevalence of BRAFV600E and TERT-p double mutation

Double mutation identified
78 (20.8%)

Disease-free survival (DFS)

Double mutation significantly correlated with shorter DFS

Original publication

Association Between Gross Features and Coexistence of BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features. Thyroid. Published 31 October 2024. doi:10.1089/thy.2024.0310

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.